How quickly does Xofluza start working?
Xofluza (baloxavir marboxil) acts rapidly against influenza A and B viruses. It inhibits viral replication by targeting the cap-dependent endonuclease enzyme, reducing infectious virus production within 24 hours after a single oral dose. In clinical trials, viral titers dropped significantly faster than with oseltamivir (Tamiflu), often by day 2.[1][2]
Time to symptom relief
Patients typically notice symptom improvement within 1-2 days. Phase 3 trials showed the median time to symptom alleviation was 54 hours for Xofluza versus 80 hours for oseltamivir in otherwise healthy adolescents and adults.[1] For high-risk patients, it shortened this to about 73 hours compared to 102 hours with standard therapy.[3]
Comparison to Tamiflu and other antivirals
| Treatment | Dose | Median time to relief (healthy adults) | Viral reduction speed |
|-----------|------|---------------------------------------|----------------------|
| Xofluza | Single dose | 54 hours | 24 hours to peak effect |
| Tamiflu | 5 days | 80 hours | Slower, multi-day |
| Peramivir | Single IV | Similar to Xofluza | Comparable but IV only |
Xofluza's single-dose convenience speeds overall treatment compared to multi-day options like Tamiflu.[1][4]
Does it work against all flu strains?
It covers influenza A (including H1N1, H3N2) and B. Reduced susceptibility occurs in some resistant strains (e.g., certain H3N2 variants), but it remains effective broadly. CDC recommends it for uncomplicated flu within 48 hours of symptoms.[2][5]
What if you take it late?
Efficacy drops if started beyond 48 hours, though some benefit persists up to 4 days in high-risk cases. Early use maximizes viral clearance.[3]
Common patient concerns on speed
Users report feeling better by day 2, but full recovery takes 3-7 days. Side effects like diarrhea or nausea rarely slow relief.[6]
[1]: New England Journal of Medicine - Baloxavir Marboxil Trial
[2]: FDA Label - Xofluza
[3]: NEJM - High-Risk Flu Trial
[4]: CDC Flu Antiviral Guidance
[5]: Resistance Data - Genentech
[6]: Drugs.com User Reviews